Cargando…
Best evidence topic: Should patients with asymptomatic choledocholithiasis be treated differently from those with symptomatic or complicated disease?
Choledocholithiasis is a common finding in clinical practice, with presentation varying from asymptomatic to life-threatening complications. In symptomatic patients, there is no doubt that treatment to clear the bile duct is indicated, but there is still a debate regarding the treatment of patients...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7820301/ https://www.ncbi.nlm.nih.gov/pubmed/33520213 http://dx.doi.org/10.1016/j.amsu.2020.12.048 |
_version_ | 1783639180937527296 |
---|---|
author | Nawara, Hossam Ibrahim, Rashid Abounozha, Sabry Alawad, Awad |
author_facet | Nawara, Hossam Ibrahim, Rashid Abounozha, Sabry Alawad, Awad |
author_sort | Nawara, Hossam |
collection | PubMed |
description | Choledocholithiasis is a common finding in clinical practice, with presentation varying from asymptomatic to life-threatening complications. In symptomatic patients, there is no doubt that treatment to clear the bile duct is indicated, but there is still a debate regarding the treatment of patients with silent common bile duct stones (CBDS). The question addressed by this best evidence topic is whether patients with asymptomatic CBDS should be managed in the same way as patients with symptoms or complications. The search strategy yielded 609 articles, from which 8 articles found to be relevant to this topic. We also summarised the most notable societal guidelines recommendations, regarding this topic. We tabulated the article title, author, year, country, study type, outcomes, results, and comments. We concluded that patients with asymptomatic CBD stones should be offered endoscopic treatment If they are fit, after discussion of the potential risks and benefits of both options of conservative and interventional treatment with the patients. |
format | Online Article Text |
id | pubmed-7820301 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Elsevier |
record_format | MEDLINE/PubMed |
spelling | pubmed-78203012021-01-29 Best evidence topic: Should patients with asymptomatic choledocholithiasis be treated differently from those with symptomatic or complicated disease? Nawara, Hossam Ibrahim, Rashid Abounozha, Sabry Alawad, Awad Ann Med Surg (Lond) Best Evidence Topic Choledocholithiasis is a common finding in clinical practice, with presentation varying from asymptomatic to life-threatening complications. In symptomatic patients, there is no doubt that treatment to clear the bile duct is indicated, but there is still a debate regarding the treatment of patients with silent common bile duct stones (CBDS). The question addressed by this best evidence topic is whether patients with asymptomatic CBDS should be managed in the same way as patients with symptoms or complications. The search strategy yielded 609 articles, from which 8 articles found to be relevant to this topic. We also summarised the most notable societal guidelines recommendations, regarding this topic. We tabulated the article title, author, year, country, study type, outcomes, results, and comments. We concluded that patients with asymptomatic CBD stones should be offered endoscopic treatment If they are fit, after discussion of the potential risks and benefits of both options of conservative and interventional treatment with the patients. Elsevier 2021-01-13 /pmc/articles/PMC7820301/ /pubmed/33520213 http://dx.doi.org/10.1016/j.amsu.2020.12.048 Text en © 2021 The Authors http://creativecommons.org/licenses/by/4.0/ This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Best Evidence Topic Nawara, Hossam Ibrahim, Rashid Abounozha, Sabry Alawad, Awad Best evidence topic: Should patients with asymptomatic choledocholithiasis be treated differently from those with symptomatic or complicated disease? |
title | Best evidence topic: Should patients with asymptomatic choledocholithiasis be treated differently from those with symptomatic or complicated disease? |
title_full | Best evidence topic: Should patients with asymptomatic choledocholithiasis be treated differently from those with symptomatic or complicated disease? |
title_fullStr | Best evidence topic: Should patients with asymptomatic choledocholithiasis be treated differently from those with symptomatic or complicated disease? |
title_full_unstemmed | Best evidence topic: Should patients with asymptomatic choledocholithiasis be treated differently from those with symptomatic or complicated disease? |
title_short | Best evidence topic: Should patients with asymptomatic choledocholithiasis be treated differently from those with symptomatic or complicated disease? |
title_sort | best evidence topic: should patients with asymptomatic choledocholithiasis be treated differently from those with symptomatic or complicated disease? |
topic | Best Evidence Topic |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7820301/ https://www.ncbi.nlm.nih.gov/pubmed/33520213 http://dx.doi.org/10.1016/j.amsu.2020.12.048 |
work_keys_str_mv | AT nawarahossam bestevidencetopicshouldpatientswithasymptomaticcholedocholithiasisbetreateddifferentlyfromthosewithsymptomaticorcomplicateddisease AT ibrahimrashid bestevidencetopicshouldpatientswithasymptomaticcholedocholithiasisbetreateddifferentlyfromthosewithsymptomaticorcomplicateddisease AT abounozhasabry bestevidencetopicshouldpatientswithasymptomaticcholedocholithiasisbetreateddifferentlyfromthosewithsymptomaticorcomplicateddisease AT alawadawad bestevidencetopicshouldpatientswithasymptomaticcholedocholithiasisbetreateddifferentlyfromthosewithsymptomaticorcomplicateddisease |